A breakthrough study published in npj Aging just introduced a refreshing alternative: a urinary microRNA aging clock. By ...

Craif Inc. in Nagoya, Japan, working with Nagoya University's Institute of Innovation for Future Society, has developed a ...

MicroRNAs (miRNAs) repress cellular protein levels to provide a sophisticated parameter of gene regulation that coordinates a broad spectrum of biological processes. Bone organogenesis is a complex ...

MicroRNAs are small evolutionarily conserved nucleotide sequences that regulate gene expression by interfering with mRNA translation and stability. MicroRNA-deficient CD4 + T cells show impaired ...

Researchers developed and validated a non-invasive urinary microRNA aging clock using extracellular vesicle miRNAs from more ...

STOCKHOLM − U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for the discovery of microRNA and its crucial role in how multicellular organisms grow and live, the ...

Victor Ambros receives funding from the U.S. National Institutes of Health. The Conversation Weekly podcast caught up with Victor Ambros from his lab at the UMass Chan Medical School to learn more ...

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Gary Ruvkun is used to getting awards — but for him, the Nobel Prize ...

US scientists Victor Ambros and Gary Ruvkun's Nobel Prize in physiology or medicine recognizes their research into microRNA. American scientists Victor Ambros and Gary Ruvkun are the latest in a long ...

American researchers Victor Ambros and Gary Ruvkun have been awarded the Nobel Prize in Physiology or Medicine. The Nobel Assembly at the Karolinska Institute, Sweden, announced the award on Monday.

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.